Pulse Biosciences Inc (DE) News

Latest updates and market news for PLSE

4 news

Mar 6 - Mar 12, 2026

Page 1

MT Newswires

7 hours ago

Sector Update: Health Care Stocks Fall Premarket Thursday

MT Newswires

9 hours ago

Pulse Biosciences Begins Enrollment for nPulse System Feasibility Study in Thyroid Cancer

📊

AI Sentiment

Positive

6/10

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Business Wire

10 hours ago

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Business Wire

3 days ago

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Share this news page

Share on Social Networks: